trending Market Intelligence /marketintelligence/en/news-insights/trending/QGt_LsY9yJqDCRCjcQOegw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Acer Therapeutics appoints chief medical officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Acer Therapeutics appoints chief medical officer

Acer Therapeutics Inc., which has merged with Opexa Therapeutics Inc., appointed William Andrews as chief medical officer to replace Robert Steiner.

Previously, Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals Inc., Santhera Pharmaceuticals Holding AG, Sepracor, and ClinQuest.